BeiGene Medical Europe
 Sign in
 
  • Virtual Congress
  • BeiGeneius Webinars
  • BeiGeneius Resources
  • About us
  • beigenemedical.info

Discussion and audience Q&A

 Back  View
Discussion and audience Q&A
 VIDEO   24:55   05/2021
 View

Alessandra Tedeschi, Joe-Elie Salem, Michael Lunn, Roger Owen, Véronique Leblond

Rating

Rate this resource

Related resources

Challenges in the diagnosis, staging, and clinical work up of Waldenström’s macroglobulinemia (WM): A practical guide to current best practice The complete webcast.
Challenges in the diagnosis, staging, and clinical work up of Waldenström’s macroglobulinemia (WM): A practical guide to current best practice The complete webcast.
BeiGeneius - Initiation of treatment for Waldenström’s macroglobulinemia: Practical guidance for starting treatment and managing complications
BeiGeneius - Initiation of treatment for Waldenström’s macroglobulinemia: Practical guidance for starting treatment and managing complications
BeiGeneius - Relapsed/refractory Waldenström’s macroglobulinemia: Key considerations for managing pre-treated patients
BeiGeneius - Relapsed/refractory Waldenström’s macroglobulinemia: Key considerations for managing pre-treated patients
 Back

This function is only available for registered users.

BeiGene Medical EU
Welcome to the BeiGene EU Medical Information Website
EuropeWorldItalySpain
I am not a healthcare professional
You are now leaving the website of BeiGene Europe (beigenemedical.info)
You are now leaving the italian website of BeiGene EU.
BeiGene Medical EU
Please check your webbrowser
BeiGene Medical Europe
beigenemedical.eu
  • Virtual Congress
  • About us
This website contains information for a broad scientific audience and may include information on products or indications that are not licensed, approved, or accessible in your country or region. Prescribing information or other medical information for products may also differ between countries or regions. Please visit beigene.com for more information.

As part of scientific exchange, BeiGene is providing the most recent abstract(s) accepted by the referenced scientific congress. The scientific information may include data/information on investigational use(s) of compounds/drugs that efficacy and safety have not been established. Information available on this webportal is not intended to promote or otherwise commercialize (directly or indirectly) any off-label or unapproved uses of BeiGene products.
© 2022 BeiGene. All Rights Reserved.
Privacy Policy | Terms of use | Imprint |